Biovision Ventures

Europe, Luxembourg, Belgium, Luxembourg

Description

Biovision Ventures is a venture capital firm.

Investor Profile

Biovision Ventures has made 3 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

Series B (33%)
Seed (33%)
Series A (33%)

Country Focus

United States (100%)

Industry Focus

Biotechnology
Therapeutics
Analytics
Medical Device
Precision Medicine
Medical
Health Care

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biovision Ventures frequently co-invest with?

KdT Ventures

North America, Texas, United States, Austin

Co-Investments: 1

Pear VC

North America, California, United States, Menlo Park

Co-Investments: 1

BEVC

North America, California, United States, Berkeley

Co-Investments: 1

IAG Capital Partners

North America, South Carolina, United States, Charleston

Co-Investments: 1

MedTex Ventures

North America, Connecticut, United States, Norwalk

Co-Investments: 1

Aphelion Capital

North America, Colorado, United States, Littleton

Co-Investments: 1

Bold Brain Ventures

North America, Pennsylvania, United States, Pittsburgh

Co-Investments: 1

NFX Bio

North America, California, United States, San Francisco

Co-Investments: 1

BlueStone Venture Partners

North America, Arizona, United States, Tucson

Co-Investments: 1

Eli Lilly

North America, Indiana, United States, Indianapolis

Co-Investments: 1

Which angels does Biovision Ventures often collaborate with?

Mei Z.

North America, United States

Shared Deals: 1

What are some of recent deals done by Biovision Ventures?

Arda Therapeutics

San Francisco, California, United States

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

BiotechnologyHealth CareTherapeutics

Series AOct 1, 2024

Amount Raised: $43,000,000

Radar Therapeutics

Berkeley, California, United States

Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.

MedicalTherapeutics

SeedMay 23, 2024

Amount Raised: $13,400,000

Elucid

Boston, Massachusetts, United States

Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.

AnalyticsBiotechnologyMedical DevicePrecision Medicine

Series BJun 22, 2022

Amount Raised: $27,000,000

Biovision Ventures

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Biovision Ventures frequently co-invest with?

Which angels does Biovision Ventures often collaborate with?

What are some of recent deals done by Biovision Ventures?

Ready to Raise Capital?

Pages

Free tools